Literature DB >> 17988075

Anthelmintic drugs.

Lindy Holden-Dye1, Robert J Walker.   

Abstract

C. elegans is sensitive to the majority of anthelmintic drugs that are used against parasitic worm infections of humans and livestock. This has provided the opportunity to use molecular genetic techniques in the worm for mode of action studies. These approaches continue to be of considerable value to the field of parasitology. In addition, there are numerous examples of anthelmintic drugs providing exceptionally useful pharmacological tools to delineate fundamental aspects of cell signalling in C. elegans. This has primarily been achieved through the use of anthelmintics in forward genetic screens followed by the mapping and characterization of genes that confer altered susceptibility to the drug. Less fruitful so far, but nonetheless useful, has been the direct use of C. elegans for anthelmintic discovery programmes. In this brief review we provide an introduction to the use of C. elegans as a 'model parasite', outline the actions of the main classes of anthelmintics, and highlight approaches that have been of particular value.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17988075      PMCID: PMC4781348          DOI: 10.1895/wormbook.1.143.1

Source DB:  PubMed          Journal:  WormBook        ISSN: 1551-8507


  43 in total

1.  Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction.

Authors:  Violetta N Pivtoraiko; Adam J Harrington; Burton J Mader; Austin M Luker; Guy A Caldwell; Kim A Caldwell; Kevin A Roth; John J Shacka
Journal:  J Neurochem       Date:  2010-06-01       Impact factor: 5.372

2.  A multispectral optical illumination system with precise spatiotemporal control for the manipulation of optogenetic reagents.

Authors:  Jeffrey N Stirman; Matthew M Crane; Steven J Husson; Alexander Gottschalk; Hang Lu
Journal:  Nat Protoc       Date:  2012-01-12       Impact factor: 13.491

3.  Nitazoxanide: nematicidal mode of action and drug combination studies.

Authors:  Vishal S Somvanshi; Brian L Ellis; Yan Hu; Raffi V Aroian
Journal:  Mol Biochem Parasitol       Date:  2014-01-08       Impact factor: 1.759

4.  Bacillus subtilis strain engineered for treatment of soil-transmitted helminth diseases.

Authors:  Yan Hu; Melanie M Miller; Alan I Derman; Brian L Ellis; Rose Gomes Monnerat; Joe Pogliano; Raffi V Aroian
Journal:  Appl Environ Microbiol       Date:  2013-07-08       Impact factor: 4.792

5.  Discovery of a highly synergistic anthelmintic combination that shows mutual hypersusceptibility.

Authors:  Yan Hu; Edward G Platzer; Audrey Bellier; Raffi V Aroian
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

6.  Cell Non-autonomous Function of daf-18/PTEN in the Somatic Gonad Coordinates Somatic Gonad and Germline Development in C. elegans Dauer Larvae.

Authors:  Claudia C Tenen; Iva Greenwald
Journal:  Curr Biol       Date:  2019-02-28       Impact factor: 10.834

Review 7.  Modeling molecular and cellular aspects of human disease using the nematode Caenorhabditis elegans.

Authors:  Gary A Silverman; Cliff J Luke; Sangeeta R Bhatia; Olivia S Long; Anne C Vetica; David H Perlmutter; Stephen C Pak
Journal:  Pediatr Res       Date:  2009-01       Impact factor: 3.756

8.  Haematophagic Caenorhabditis elegans.

Authors:  Veeren M Chauhan; David I Pritchard
Journal:  Parasitology       Date:  2018-10-25       Impact factor: 3.234

9.  The new anthelmintic tribendimidine is an L-type (levamisole and pyrantel) nicotinic acetylcholine receptor agonist.

Authors:  Yan Hu; Shu-Hua Xiao; Raffi V Aroian
Journal:  PLoS Negl Trop Dis       Date:  2009-08-11

10.  Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1.

Authors:  Brian Onken; Monica Driscoll
Journal:  PLoS One       Date:  2010-01-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.